WX-UK1 in combination with Capecitabine
WX/50-005
Phase 1 small_molecule completed
Quick answer
WX-UK1 in combination with Capecitabine for Advanced Malignancies is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Advanced Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed